Breaking News, Financial News

Financial Report: Pfizer 2Q

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Pfizer 2Q Revenues: $12.1 billion (+9%) 2Q Earnings: $2.8 billion (+119%) YTD Revenues: $24.0 billion (+2%) YTD Earnings: $5.6 billion (+19%) Comments: Pharmaceutical sales in the quarter were $11.1 billion (+9%) and $22.0 billion YTD (+1%), including exchange rate benefits of $800 million in 1Q08. Lipitor revenues in the quarter were $3.0 billion (+9%). Lyrica revenues in the quarter were $614 million (+52%). Celebrex revenues were $589 million (+23%). Sutent revenues were $211 m...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters